Cervical cancer

Benjamin E. Greer; Wui Jin Koh; Nadeem R. Abu-Rustum; Michael A. Bookman; Robert E. Bristow; Susana Campos; Kathleen R. Cho; Larry Copeland; Patricia Eifel; Warner K. Huh; Wainwright Jaggernauth; Daniel S. Kapp; John Kavanagh; Gary H. Lipscomb; John R. Lurain; Mark Morgan; Robert J. Morgan; C. Bethan Powell; Steven W. Remmenga; R. Kevin Reynolds; Angeles Alvarez Secord; William Small; Nelson Teng

doi:10.6004/jnccn.2008.0003

Cervical cancer

Benjamin E. Greer, Wui Jin Koh, Nadeem R. Abu-Rustum, Michael A. Bookman, Robert E. Bristow, Susana Campos, Kathleen R. Cho, Larry Copeland, Patricia Eifel, Warner K. Huh, Wainwright Jaggernauth, Daniel S. Kapp, John Kavanagh, Gary H. Lipscomb, John R. Lurain, Mark Morgan, Robert J. Morgan, C. Bethan Powell, Steven W. Remmenga, R. Kevin ReynoldsAngeles Alvarez Secord, William Small, Nelson Teng

Research output: Contribution to journal › Review article › peer-review

11 Scopus citations

Abstract

Although cervical cancer is decreasing in the United States, because screening is widely used, it is increasing in developing countries (approximately 270,000 deaths per year), because screening is not available to many women. Effective treatment for cervical cancer (e.g., surgery, concurrent chemoradiation) can yield cures in 80% of women with early-stage disease (stages I and II) and in 60% with stage III disease. The hope is that immunization against HPV (using the new vaccines) will prevent persistent infection with certain types of HPV, and is therefore expected to prevent specific HPV cancer in women.^9,69

Original language	English (US)
Pages (from-to)	14-36
Number of pages	23
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	6
Issue number	1
DOIs	https://doi.org/10.6004/jnccn.2008.0003
State	Published - Jan 2008
Externally published	Yes

Keywords

Cervical cancer
Chemotherapy
Human papillomavirus
Hysterectomy
NCCN clinical practice guidelines
Radiation therapy

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2008.0003

Cite this

Greer, B. E., Koh, W. J., Abu-Rustum, N. R., Bookman, M. A., Bristow, R. E., Campos, S., Cho, K. R., Copeland, L., Eifel, P., Huh, W. K., Jaggernauth, W., Kapp, D. S., Kavanagh, J., Lipscomb, G. H., Lurain, J. R., Morgan, M., Morgan, R. J., Powell, C. B., Remmenga, S. W., ... Teng, N. (2008). Cervical cancer. JNCCN Journal of the National Comprehensive Cancer Network, 6(1), 14-36. https://doi.org/10.6004/jnccn.2008.0003

Greer, BE, Koh, WJ, Abu-Rustum, NR, Bookman, MA, Bristow, RE, Campos, S, Cho, KR, Copeland, L, Eifel, P, Huh, WK, Jaggernauth, W, Kapp, DS, Kavanagh, J, Lipscomb, GH, Lurain, JR, Morgan, M, Morgan, RJ, Powell, CB, Remmenga, SW, Reynolds, RK, Secord, AA, Small, W & Teng, N 2008, 'Cervical cancer', JNCCN Journal of the National Comprehensive Cancer Network, vol. 6, no. 1, pp. 14-36. https://doi.org/10.6004/jnccn.2008.0003

@article{a20aa9d95d4a4c588e384cc11bc9fc79,

title = "Cervical cancer",

abstract = "Although cervical cancer is decreasing in the United States, because screening is widely used, it is increasing in developing countries (approximately 270,000 deaths per year), because screening is not available to many women. Effective treatment for cervical cancer (e.g., surgery, concurrent chemoradiation) can yield cures in 80% of women with early-stage disease (stages I and II) and in 60% with stage III disease. The hope is that immunization against HPV (using the new vaccines) will prevent persistent infection with certain types of HPV, and is therefore expected to prevent specific HPV cancer in women.9,69",

keywords = "Cervical cancer, Chemotherapy, Human papillomavirus, Hysterectomy, NCCN clinical practice guidelines, Radiation therapy",

author = "Greer, {Benjamin E.} and Koh, {Wui Jin} and Abu-Rustum, {Nadeem R.} and Bookman, {Michael A.} and Bristow, {Robert E.} and Susana Campos and Cho, {Kathleen R.} and Larry Copeland and Patricia Eifel and Huh, {Warner K.} and Wainwright Jaggernauth and Kapp, {Daniel S.} and John Kavanagh and Lipscomb, {Gary H.} and Lurain, {John R.} and Mark Morgan and Morgan, {Robert J.} and Powell, {C. Bethan} and Remmenga, {Steven W.} and Reynolds, {R. Kevin} and Secord, {Angeles Alvarez} and William Small and Nelson Teng",

year = "2008",

month = jan,

doi = "10.6004/jnccn.2008.0003",

language = "English (US)",

volume = "6",

pages = "14--36",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "1",

}

TY - JOUR

T1 - Cervical cancer

AU - Greer, Benjamin E.

AU - Koh, Wui Jin

AU - Abu-Rustum, Nadeem R.

AU - Bookman, Michael A.

AU - Bristow, Robert E.

AU - Campos, Susana

AU - Cho, Kathleen R.

AU - Copeland, Larry

AU - Eifel, Patricia

AU - Huh, Warner K.

AU - Jaggernauth, Wainwright

AU - Kapp, Daniel S.

AU - Kavanagh, John

AU - Lipscomb, Gary H.

AU - Lurain, John R.

AU - Morgan, Mark

AU - Morgan, Robert J.

AU - Powell, C. Bethan

AU - Remmenga, Steven W.

AU - Reynolds, R. Kevin

AU - Secord, Angeles Alvarez

AU - Small, William

AU - Teng, Nelson

PY - 2008/1

Y1 - 2008/1

N2 - Although cervical cancer is decreasing in the United States, because screening is widely used, it is increasing in developing countries (approximately 270,000 deaths per year), because screening is not available to many women. Effective treatment for cervical cancer (e.g., surgery, concurrent chemoradiation) can yield cures in 80% of women with early-stage disease (stages I and II) and in 60% with stage III disease. The hope is that immunization against HPV (using the new vaccines) will prevent persistent infection with certain types of HPV, and is therefore expected to prevent specific HPV cancer in women.9,69

AB - Although cervical cancer is decreasing in the United States, because screening is widely used, it is increasing in developing countries (approximately 270,000 deaths per year), because screening is not available to many women. Effective treatment for cervical cancer (e.g., surgery, concurrent chemoradiation) can yield cures in 80% of women with early-stage disease (stages I and II) and in 60% with stage III disease. The hope is that immunization against HPV (using the new vaccines) will prevent persistent infection with certain types of HPV, and is therefore expected to prevent specific HPV cancer in women.9,69

KW - Cervical cancer

KW - Chemotherapy

KW - Human papillomavirus

KW - Hysterectomy

KW - NCCN clinical practice guidelines

KW - Radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=38949136630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38949136630&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2008.0003

DO - 10.6004/jnccn.2008.0003

M3 - Review article

C2 - 18267056

AN - SCOPUS:38949136630

SN - 1540-1405

VL - 6

SP - 14

EP - 36

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 1

ER -

Cervical cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this